Mobile Menu

Search Results

Search results for: ROI

Novartis: Data landscaping, FAIR play, FAIRification, killer apps and the ROI question

In his keynote presentation at D4 in Basel last October, Philippe Marc, Global Head Integrated Data Sciences at Novartis, set […]

Developing drugs for Parkinson’s disease

Current treatments for Parkinson’s disease are mainly dopaminergic drugs. However, these are limited by several side effects and can only […]

Real-world evidence in regulatory decision making

Real-world evidence can be used to show that a drug or medical device is safe and effective. The FDA has […]

An AI radiology workflow

Here we summarise a recent review article, published in Neuroimaging Clinics, that explored the additive value of artificial intelligence (AI) […]

Reach for the stars: Star-shaped device releases drugs more efficiently

Researchers from John Hopkins have developed a star-shaped device that can latch onto intestinal mucosa and release drugs into the […]

New artificial intelligence study of Alzheimer’s

The National Institutes of Health (NIH) have funded a five-year effort to use state-of-the-art artificial intelligence methods to study Alzheimer’s […]

Multimodality MRI and ML techniques in bipolar disorder identification

Researchers have combined structural and functional magnetic resonance imaging (MRI) with machine learning (ML) techniques to aid in accurately identifying […]

Drug repurposing in Alzheimer’s disease

A recent review, in Nature Reviews Neurology, has provided an overview of the promising compounds for clinical trials in individuals […]

Fighting COVID-19 with drug repurposing

A recent review, published in Pharmacological Reports, discusses the current efficacy of drug repurposing against COVID-19. The search The race […]

Integration of ML in the diagnosis and treatment of neurodegenerative diseases

A recent Nature review, describes the latest developments in the use of machine learning approaches to interrogate datasets in neurodegenerative […]